<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36233443</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Determinants of Chronic Pain Post-COVID; Cross-Sectional Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5569</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11195569</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Chronic pain is increasingly recognized as part of long COVID syndrome, mainly in the form of myalgias. However, chronic pain has several forms, and according to our clinical experience, COVID-19 survivors suffer from numerous painful syndromes, other than myalgias. The aim of our study was to estimate the prevalence of chronic pain, describe the commonest painful syndromes and identify pain determinants in a random population of COVID-19 survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional study conducted at the Medical School, University of Cyprus. A random population of 90 COVID-19 survivors was recruited. Demographic and COVID-19 related clinical characteristics were recorded. The painDETECT and DN4 questionnaires were used to evaluate the painful syndromes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of chronic pain was estimated to be 63.3%. The most common site of pain was low back (37.8%), followed by joints (28.9%) and neck (12.2%). Patients with chronic pain compared to subjects without pain were older (50.5 &#xb1; 15.9 versus 42.2 &#xb1; 12.6, <i>p</i> = 0.011) and more likely to be female (71.9% versus 45.5%, <i>p</i> = 0.013). One in six subjects (16.7%) reported new-onset pain post COVID-19. The prevalence of neuropathic pain was estimated to be 24.4%. After adjusting for age and gender, headache during COVID-19 was a statistically significant predictor of neuropathic pain, increasing 4.9 times (95% 1.4-16.6, <i>p</i> = 0.011) the odds of neuropathic pain.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Chronic pain-especially neuropathic-is widely prevalent in COVID-19 survivors. One in six subjects will develop new-onset pain that will persist beyond the acute phase of the disease and, therefore, should be considered a symptom of long COVID syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zis</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8567-3092</Identifier><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioannou</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2309-0489</Identifier><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artemiadis</LastName><ForeName>Artemios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christodoulou</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nicosia New General Hospital, Nicosia 2029, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalampokini</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4541-5384</Identifier><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjigeorgiou</LastName><ForeName>Georgios M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0001-5386-4273</Identifier><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chronic pain</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuropathic pain</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36233443</ArticleId><ArticleId IdType="pmc">PMC9573502</ArticleId><ArticleId IdType="doi">10.3390/jcm11195569</ArticleId><ArticleId IdType="pii">jcm11195569</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Izquierdo-Dominguez A., Rojas-Lechuga M.J., Mullol J., Alobid I. Olfactory dysfunction in the COVID-19 outbreak. J. Investig. Allergol. Clin. Immunol. 2020;30:317&#x2013;326. doi: 10.18176/jiaci.0567.</Citation><ArticleIdList><ArticleId IdType="doi">10.18176/jiaci.0567</ArticleId><ArticleId IdType="pubmed">32406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A., Kneen R., Defres S., Sejvar J., Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev. Neurol. 2019;175:16&#x2013;25. doi: 10.1016/j.neurol.2018.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2018.09.016</ArticleId><ArticleId IdType="pubmed">30385075</ArticleId></ArticleIdList></Reference><Reference><Citation>Freynhagen R., Baron R., Gockel U., T&#xf6;lle T.R. painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin. 2006;22:1911&#x2013;1920. doi: 10.1185/030079906X132488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079906X132488</ArticleId><ArticleId IdType="pubmed">17022849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhassira D., Attal N., Alchaar H., Boureau F., Brochet B., Bruxelle J., Cunin G., Fermanian J., Ginies P., Grun-Overdyking A., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) Pain. 2005;114:29&#x2013;36. doi: 10.1016/j.pain.2004.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2004.12.010</ArticleId><ArticleId IdType="pubmed">15733628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykioti P., Zis P., Vadalouca A., Siafaka I., Argyra E., Bouhassira D., Stavropoulou E., Karandreas N. Validation of the Greek version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Pract. 2015;15:627&#x2013;632. doi: 10.1111/papr.12221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.12221</ArticleId><ArticleId IdType="pubmed">24796220</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills S.E.E., Nicolson K.P., Smith B.H. Chronic pain: A review of its epidemiology and associated factors in population-based studies. Br. J. Anaesth. 2019;123:e273&#x2013;e283. doi: 10.1016/j.bja.2019.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.03.023</ArticleId><ArticleId IdType="pmc">PMC6676152</ArticleId><ArticleId IdType="pubmed">31079836</ArticleId></ArticleIdList></Reference><Reference><Citation>Yawn B.P., Wollan P.C., Weingarten T.N., Watson J.C., Hooten W.M., Melton L.J., 3rd The prevalence of neuropathic pain: Clinical evaluation compared with screening tools in a community population. Pain Med. 2009;10:586&#x2013;593. doi: 10.1111/j.1526-4637.2009.00588.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2009.00588.x</ArticleId><ArticleId IdType="pmc">PMC2964880</ArticleId><ArticleId IdType="pubmed">20849570</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>